chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the vaccination, and at first all I really had was the sore arm and fatigue. A week later, on the 20th, I woke up itching really bad on the inside of my thighs. Little bumps, looked like little mosquito bites. I thought it may have been a heat rash because of where I live, so I used some lotion to help. The next day it had spread up to my hips and my back. It continued to spread to my stomach and underarms. The only thing I had done in the last 30 days was the vaccination. No change in meds, foods. I made an appointment with my doctor and we went over the same things, and also thought the only thing it could be was the vaccine, she had seen it with a few other patients with an auto-immune disorder. She gave me a steroid shot and a prescription for an antihistamine because the itching was so bad it kept me awake at night. She also gave me a prescription of a step down steroid. Since then I've been taking the antihistamines 3x daily, it's been slowly getting better but there is still some itching. I still have a few more days on the steroid, and I'm hoping this will be cleared up by Thursday at the end of it. The PA didn't run any blood work or labs at that time because the day before my reaction I had been in for a physical and they had done all of that and everything came back normal.
Urinary tract infection; Escherichia coli infection; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received second dose of BNT162B2 (BNT162B2, Solution for injection, Lot number: EN6208), intramuscularly, on 09Mar2021, as a single dose for COVID-19 immunisation. The patient received Adalimumab (HUMIRA 40MG/0.4ML, Solution for injection in pre-filled pen) at an unknown dose subcutaneously from an unspecified date in May2021 for rheumatoid arthritis. Medical history included ear infection (started Jan2021), non-tobacco user, non alcohol user and sulfa drugs allergy manifested as rash. Concomitant medications were not reported. The patient previously received first dose of BNT162B2 (Lot Number: EN6201), intramuscularly, on 16Feb2021 as single dose for COVID-19 immunisation with no reaction on previous exposure to vaccine. The patient's past medications include SULFA and Etanercept (ENBREL). In Jun2021, the patient experienced urinary tract infection and Escherichia coli infection. The patient went to an urgent care due to urinary tract infection on 09Jun2021. Physician asked her to skip Adalimumab when was informed about the infection. On 04Jun2021, therapy with Adalimumab was discontinued. She had a shot of COVID 19 vaccine before at least one symptom happened therefore COVID-19 VACCINE was considered as co-suspect product. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The patient was treated with Clarithromycin (MACROBID). Relevant Laboratory & Other Diagnostic Tests included Dipstick culture performed in Jun2021 that confirmed there was Escherichia coli and urinary tract infection. Outcome of the events was unknown. The reporter's causality for the events of urinary tract infection and Escherichia coli infection with BNT162B2 was not related and with Adalimumab was no reasonable possibility.  No follow-up attempts are needed. No further information is expected.
Twitching of eyelid in left eye. Happened for 3 weeks following first injection. Left eye would twitch 10-15 times a day. On the second week, right eye began twitching a few times a day, but primarily happened in left eye. Symptom subsided as of 4/28/21
Right after administration, patient developed excessive swelling and some bleeding. She was monitored for 15 mins. then she was advised to put some ice! She was contacted same evening and next day. Swelling was going away.
This spontaneous report as received from a pharmacist refers to a 61-year-old male patient. The patient had no concomitant medications, pertinent medical history, drug reactions or allergies. On 12-APR-2017, the patient was vaccinated with ZOSTAVAX, lot # M035693 with expiry date on 07-NOV-2017 (dose and route of administration were not reported) for prophylaxis. On the same day, after the administration of ZOSTAVAX, the patient began to experience tingling at the injection site. No treatment was given for the event and no laboratory diagnostics studies were performed. The patient did not seek a medical attention. Product quality complaint (PQC) was not involved. The outcome of the event was reported as recovered on the same day. The relatedness between the event and ZOSTAVAX was not reported. Additional information has been requested.
On the night I received the vaccine I started having continuous heart palpitations. They did not stop and were causing me a lot of discomfort. I have had a cardiac work up in the past, which was all clear. I contacted my cardiologist and she had me come in for an EKG. The EKG showed bigeminy and trigeminy. She prescribed me metoprolol 25 mg BID, but it didn't help. It was worsening over the course of several days and I went to the hospital because I was in so much discomfort and on repeated EKGs the irregular rhythm continued.  While in the EKG they gave me IV labetalol and made a referral to an electrophysiologist. They put me on a Holter monitor for continuous monitoring for 5 days. By the time I had my appointment with the EP the palpitations had mostly subsided. The irregular rhythm lasted 2 weeks continuously, then stopped spontaneously after 2 weeks and I haven't had them since.
Developed a full facial rash and down on her back as well; This is a spontaneous report from a contactable consumer via medical information team. A female patient of an unspecified age received pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) (PREVNAR 13, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for immunization. The patient medical history and concomitant medications were not reported. It was reported that after receiving the vaccine on an unknown date, the patient developed a full facial rash and down on her back as well. The reporter has done what she could to help treat the skin of the patient, and she talked to the pediatrician and sent her some pictures, but she mentioned that she could not be sure if the rash was caused by the vaccine until she sees it in person. The outcome of the event was unknown.   No follow-up attempts are possible. Information about batch/lot number cannot be obtained. No further information is expected.
Patient's mother came to pharmacy in the drive thru to pick up antibiotic for daughter on 9/18/19.  During consultation with RPH mom expressed concern over daughter's vaccination.  She said daughter had immediate pain in her arm after vaccine was administered and her shoulder and arm hurt for days.  She had never had a reaction to a vaccine before.  After a few days patient was seen by her doctor and may have been told that vaccine was administered incorrectly.  Patient's pain has gotten better but will come back at times and be very painful again.
24 hours after vaccine administration, my entire upper arm was swollen three times its size and had a rash approximately 6x8 inches. Rash was hot and burning, Swelling went down after 24 hours of icing and Advil.  MARCH 3 EVENT - Began noticing rash like appearance on feet and ankles. March 10 diagnosed with vasculitis. Started prednisone treatment  March 11.
Patient came in for bivalent Pfizer vaccine and received the original Pfizer vaccine instead.
PATIENT WAS ASKED TO WAIT AT THE WAITING AREA FOR 15 MINS AFTER RECEIVING THE VACCINE. IN FEW MINUTES SHE SLOWLY WALKED UP TOWARDS MY WORKSTATION AND I QUICKLY RAN OUT AND GRABBED HER BECAUSE I COULD TELL SOMETHING WAS WRONG. A CUSTOMER STANDING BY GRABBED A CHAIR FOR HER AND WE  HAD HER SIT DOWN. THEN SHE TOLD ME SHE GOT UP TO GET WATER AND SHE PASSED OUT. I TOLD HER ITS BETTER THAT SHE  LAYS DOWN ON THE FLOOR TO PREVENT ANY FURTHER INJURIES AND I HELPED HER TO  LAY DOWN. SHE WAS SWEATING AND SHE STATED THAT HAD TROUBLE WITH HER VISION AND HEARING. PARAMEDICS WERE IMMEDIATELY NOTIFIED. MEANWHILE SHE STATED SHE WAS ANXIOUS TO GET THE SHOT AND SHE DIDN'T HAVE BREAKFAST. SO WE GAVE HER WATER, ORANGE JUICE AND CRACKERS. BY THE TIME THE PARAMEDICS ARRIVED SHE STATED HER VISION AND HEARING IS BACK TO NORMAL. PATIENT ALSO WAS FEELING BETTER. PARAMEDICS CHECKED HER BLOOD PRESSURE AND ASKED IF SHE TAKES ANY MEDICATION AND SHE SAID SHE TAKES A ANXIETY MEDICATION AND I AM NOT SURE IF SHE TOOK ANY THAT MORNING. SHE WAS ASKED IF SHE WANTED TO GO THE HOSPITAL AND SHE SAID NO BECAUSE EVERYTHING WAS BACK TO NORMAL. PATIENT WALKED OUT OF THE PHARMACY FEELING BETTER.
SOB, scratchy throat, palpitations, elevated blood pressure - sent to emergency room for evaluation. (No local reaction noted).
Dizzyness, high-grade fever, breathing issues, muscle and joint pain, chills, night sweats, nausea. No treatment other than trying to sleep and hope it goes away in the morning.  This morning I feel very dizzy, still have a headache, and still have a fever.
Severe DAILY diarrhea since the 2nd shot; begins EARLY in the am (6 am), occurs after coffee and each meal.   My daughter, who had the Moderna vaccines, and my Mother, who also had the Moderna vaccines ALSO have the severe diarrhea.  My 84 year old mother has lost 12 pounds due to it.
Person received Covid 19 Booster vaccine of Pfizer at vaccine event on 03/23/2022. Started to have side effects on 03/24/2022, which states  Headache, Fever (temp unknown) just keep getting cold and hot episodes, chills, and Body aches, Took Advil to help alleviate some pain and help with fever. Will Continue  to monitor her side effects for the next 48 hours
Starting about 3 days after the injection, I began experiencing pain in my joints.  It felt like arthritis, swollen, hot.  It hurts to walk, it hurts to lay, it hurts to use my fingers at times.  Today is Tuesday and this has been going on for 4 days.   Ice helps some.  So does Titanium power tape.
This spontaneous report was received from a female patient of unknown age regarding herself. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date the patient was vaccinated with GARDASIL (lot#, expiration date, strength, dosing details and route of administration were not reported) for prophylaxis. On an unknown date, the patient felt she received defective product (poor quality drug administered and product quality issue) and asked if company knew the lot number of the GARDASIL she had received. The outcome of product quality issue was unknown. Causality assessment was not provided by the reporter.
Dose received: 3; Largely Swollen lymph nodes under left arm; Elevated heart rate; Chills; Bad back pain; Muscle aches; Fever; Headache; This is a spontaneous report from a contactable reporter (consumer or other non-HCP). The reporter is the patient.  A 16-year-old male patient received bnt162b2 (BNT162B2), administered in left arm, administration date 07Jan2022 at 12:00 (Lot number: FJ8762) at the age of 16 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "None". The patient did not take any concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: EW0173, Route of Administration: unspecified, Anatomical site: Left Arm), administration date: 13May2021, when the patient was 15 year(s) old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE, Lot number: EW0191, Route of Administration: unspecified, Anatomical site: Left Arm), administration date: 03Jun2021, when the patient was 15 year(s) old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 07Jan2022 at 12:00, outcome "unknown", described as "Dose received: 3"; LYMPHADENOPATHY (non-serious) with onset 07Jan2022, outcome "recovering", described as "Largely Swollen lymph nodes under left arm"; HEART RATE INCREASED (non-serious) with onset 07Jan2022, outcome "recovering", described as "Elevated heart rate"; CHILLS (non-serious) with onset 07Jan2022, outcome "recovering", described as "Chills"; BACK PAIN (non-serious) with onset 07Jan2022, outcome "recovering", described as "Bad back pain"; MYALGIA (non-serious) with onset 07Jan2022, outcome "recovering", described as "Muscle aches"; PYREXIA (non-serious) with onset 07Jan2022, outcome "recovering", described as "Fever"; HEADACHE (non-serious) with onset 07Jan2022, outcome "recovering", described as "Headache". Relevant laboratory tests and procedures are available in the appropriate section. It was unknown whether any therapeutic measures were taken as a result of the events.  Additional information: The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care.
Day 5: Mild diarrhea getting progressively worse until day 7 with onset of severe incapacitating  vertigo, which prevented ability to get out of bed. Now at day 9, severe abdominal pain radiates to lower back with severe lower back pain. Unable to leave bedroom for the last 48 hours. Received a negative COVID-19 rapid test from spouse today (day 9). Unable to leave bedroom for treatment at doctor due to vertigo, diarrhea, abdominal and lower back pain. Also, large amounts of blood spit out on two occasions while brushing teeth (approximately 2 tablespoons). I am not sure where all the blood came from. May be a dental issue because it occurred during brushing but has never happened before.
Breakthrough case admission after three vaccines  Pfizer 3/22/22 Lot# FJ5683;  MOderna 4/6/22 Lot# 057M21A;  Pfizer 10/27/22 Lot# GH9702
Whenever I scratch or irritate my skin in any way, Hive-like rashes appear.
Mom stated child had congestion, sweats, tiredness and cough since given FLUMIST. Advised to use asthma meds and follow up w/ MD if symptoms worsen.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: Patient had no known allergies. She did not receive any other medications in 2 weeks. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
swelling under armpit of administered arm; Pain at injection site; fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling under armpit of administered arm), VACCINATION SITE PAIN (Pain at injection site) and PYREXIA (fever) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Spina bifida. Concomitant products included SULFAMETHOXAZOLE, TRIMETHOPRIM (BACTRIM DS) for an unknown indication.   On 05-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, the patient experienced PYREXIA (fever). On 07-May-2021, the patient experienced PERIPHERAL SWELLING (swelling under armpit of administered arm) and VACCINATION SITE PAIN (Pain at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (swelling under armpit of administered arm), VACCINATION SITE PAIN (Pain at injection site) and PYREXIA (fever) outcome was unknown. Not Provided     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable.
Afib; sometimes sharp and sometimes dull pains that would last 10-60 seconds throughout her body-calfs, things, forearms, toes, finger and even his stomach; sometimes sharp and sometimes dull pains that would last 10-60 seconds throughout her body-calfs, things, forearms, toes, finger and even his stomach; sometimes sharp and sometimes dull pains that would last 10-60 seconds throughout her body-calfs, things, forearms, toes, finger and even his stomach; This is a spontaneous report from a contactable consumer (patient). A 55-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 03Mar2021 (Batch/Lot Number: EN6198) (age at vaccination: 55-year-old) as SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported. Concomitant medications included nebivolol nebivolol hydrochloride (BYSTOLIC) taken for an unspecified indication from 2013 and ongoing; doxycycline (ORACEA) taken for an unspecified indication from Jul2020 and ongoing. Historical vaccine included first dose of bnt162b2 (Batch/Lot number: EC9269) on 02Feb2021 as single dose in Left arm for covid-19 immunisation.  The patient had been experiencing pains on and off for about5-6 days after his first slot. Then he read an article (he swear, he was not researching anything online) about a 56 year old man who developed ITP days after receiving Pfizer vaccine. since he had Afib this article worried him. He had no idea what blood clots felt like, but he was having sometimes sharp and sometimes dull pains that would last 10-60 seconds throughout her body-calfs, things, forearms, toes, finger and even his stomach. The doppal came back negative. The doctor suggested symptoms finally disappeared for good about two days after his second dose. The outcome of the events was unknown.
Fever, chills, muscle aches, lethargy.  Symptoms would come and go, were not continuous.  Lasting 8 days.  Took ibuprofen and rested.  This was my third (booster) shot.  First two shots did not have adverse symptoms.
p/inj pt behavior odd-inappropriate laugh c/o not feeling well;nurses observation of ataxia, tremors to hands;dazed appearing parent notified & pt taken to MD;mom reports during follow up that swelling to inj shoulder & 2 inch rash noted;
Administered influenza vaccine with a 5/8 inch needle - no adverse event This spontaneous case initially received on 30-Sep-2016, was reported by a health professional and concerns a female patient. Weight: not provided; Height: not provided Administration of company suspect drug(s): The patient received AFLURIA from 20-SEP-2016 to 20-SEP-2016. Dosage regimen: 0.5 ml as one single dose, Route of administration: Subcutaneous. Batch number: Not reported. No additional suspect drugs. Adverse event description: On 20-Sep-2016, the patient was administered influenza vaccine with a 5/8 inch needle (special circumstances: drug administration error without adverse event). The reporter is concerned that it may have not reached the muscle in the patient. Reporter comments: The healthcare professional classified the event as a medication error.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. There was no concomitant medications, concurrent conditions and medical history reported. On 24-NOV-2015, the patient received an expired dose of ZOSTAVAX (dose, route of administration were not reported) lot # K010628 exp. 30-OCT-2015. There was no adverse event reported. Additional information has been requested.
My daughter had an absent seizure, she started to stare into space, unblinking (after fussing and getting quiet), was unresponsive to her name, lasted for roughly 20-40 seconds, then she started fussing and acting normal again.  the next day she was severely upset for the entire day.
Client reported lightheadedness 4 minutes after vaccination.  Visibly pale.  Monitored by onsite EMS for 30 minutes.  Reported that he felt better.  Declined further monitoring.  Encouraged to follow up with PCP or emergency services if needed.  Verbalized understanding.  Driven off site by his mother.
took, both of the vaccines Pfizer one, two, we also took both of the boosters/contracted Covid; took, both of the vaccines Pfizer one, two, we also took both of the boosters/contracted Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "took, both of the vaccines Pfizer one, two, we also took both of the boosters/contracted Covid". Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient took, both of the vaccines Pfizer one, two. Patient also took both of the boosters. Patient contracted Covid which before last but he was able to get his infusion with antibodies.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient reported 9/18/2014 that his (Rt) deltoid was red, itchy, swollen, sore and the skin was hot and scaly.
Shortly after my second dose of the Pfizer Covid-19 vaccine, tinnitus increased quite dramatically. At 61 years of age, some degree of very mild tinnitus was present before vaccination. The increase after the second dose was subjectively quite substantial and enough to cause issues with sleep. Now at 63 years of age, the amplitude of noise has increased and am experiencing issues with concentration and short term memory loss.
hypertension; This is a spontaneous report from a contactable consumer or other non-HCP (patient). A 71-years-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: UNKNOWN), via an unspecified route of administration on an unspecified date (age at the time of vaccination 71-years-old), as a single dose for COVID-19 immunization. The patient's medical history included Smoker. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced hypertension. Reporter stated, my wife and I have each had a Pfizer double jab and would like to know if we can volunteer for a booster clinical trial. The patient on hypertension medication received treatment for adverse event. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
I started having a mild cough on 4/5/2021, by today the cough is bad. I?m having mild trouble breathing, get short of breath when I talking and have lots of phlegm. Very lethargic and sometimes having trouble articulating. Haven?t seen a specialist yet.